Serum X-box-binding protein 1 levels in PCOS patients

References

• Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab. 1999;84(6):1897–1899.
   PubMed Web of Science ®Google Scholar
• Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril. 2005;83(5):1343–1346.
   PubMed Web of Science ®Google Scholar
• Dumesic DA, Padmanabhan V, Abbott DH. Polycystic ovary syndrome and oocyte developmental competence. Obstet Gynecol Surv. 2008;63(1):39–48.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19:41.
   PubMed Web of Science ®Google Scholar
• Franks S, McCarthy M. Genetics of ovarian disorders: polycystic ovary syndrome. Rev Endocr Metab Disord. 2004;5(1):69–76.
   PubMed Web of Science ®Google Scholar
• Svendsen PF, Nilas L, Nørgaard K, et al. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod. 2008;23(9):2113–2121.
   PubMed Web of Science ®Google Scholar
• Legro RS, Castracan VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004;59(2):141–154.
   PubMed Web of Science ®Google Scholar
• Dunaif A, Wu X, Lee A, et al. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab. 2001;281(2):E392–9.
   PubMed Web of Science ®Google Scholar
• Barbieri RL, Makris A, Ryan KJ. Effects of insulin on steroidogenesis in cultured porcine ovarian theca. Fertil Steril. 1983;40(2):237–241.
   PubMed Web of Science ®Google Scholar
• Gambineri A, Pelusi C, Vicennati V, et al. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002;26(7):883–896.
   PubMed Web of Science ®Google Scholar
• Azziz R, Ehrmann D, Legro RS, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. JclinEndocrinolMetab. 2001;86(4):1626–1632.
   PubMed Web of Science ®Google Scholar
• Piperi C, Adamopoulos C, Papavassiliou AG. XBP1: a pivotal transcriptional regulator of glucose and lipid metabolism. Trends Endocrinol Metab. 2016;27(3):119–122.
   PubMed Web of Science ®Google Scholar
• Yoshida H. Unconventional splicing of XBP-1 mRNA in the unfolded protein response. Antioxid Redox Signal. 2007;9(12):2323–2333.
   PubMed Web of Science ®Google Scholar
• Argemí J, Kress TR, Chang HCY, et al. X-box binding protein 1 regulates unfolded protein, acute-phase, and DNA damage responses during regeneration of mouse liver. Gastroenterology. 2017;152(5):1203–1216.e15.
   PubMed Web of Science ®Google Scholar
• Imanikia S, Sheng M, Castro C, et al. XBP-1 remodels lipid metabolism to extend longevity. Cell Rep. 2019;28(3):581–589.
   PubMed Web of Science ®Google Scholar
• Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306(5695):457–461.
   PubMed Web of Science ®Google Scholar
• Sha H, He Y, Yang L, et al. Stressed out about obesity: IRE1α-XBP1 in metabolic disorders. Trends Endocrinol Metab. 2011;22(9):374–381.
   PubMed Web of Science ®Google Scholar
• Akiyama M, Liew CW, Lu S, et al. X-box binding protein 1 is essential for insulin regulation of pancreatic α-cell function. Diabetes. 2013;62(7):2439–2449.
   PubMed Web of Science ®Google Scholar
• Wu R, Zhang QH, Lu YJ, et al. Involvement of the IRE1a-XBP1 Pathway and XBP1s-dependent transcriptional reprogramming in metabolic diseases. DNA Cell Biol. 2015;34(1):6–18.
   PubMed Web of Science ®Google Scholar
• Luo P, Zhang C, He Y, et al. Several circulating biomarkers for PCOS diagnosis. Exp Clin Endocrinol Diabetes. 2019;4.
   Web of Science ®Google Scholar
• Elci E, Kaya C, Cim N, et al. Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries. GynecolEndocrinol. 2017;33(1):43–47.
   Google Scholar
• Wang Y, Xie X, Zhu W. Serum adiponectin and resistin levels in patients with polycystic ovarian syndrome and their clinical implications. J Huazhong Univ Sci Technol [Med Sci]. 2010;30(5):638–642.
   PubMedGoogle Scholar
• Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8(7):519–529.
   PubMed Web of Science ®Google Scholar
• Harada M, Nose E, Takahashi N, et al. Evidence of the activation of unfolded protein response in granulosa and cumulus cells during follicular growth and maturation. Gynecol Endocrinol. 2015;31(10):783–787.
   PubMed Web of Science ®Google Scholar
• Guzel E, Arlier S, Guzeloglu-Kayisli O, et al. Endoplasmic reticulum stress and homeostasis in reproductive physiology. IJMS. 2017;18(4):792.
   Google Scholar
• Takahashi N, Harada M, Hirota Y, et al. Activation of endoplasmic reticulum stress in granulosa cells from patients with polycystic ovary syndrome contributes to ovarian fibrosis. Sci Rep. 2017;7(1):10824.
   PubMedGoogle Scholar
• Bañuls C, Rovira-Llopis S, Martinez de Marañon A, et al. Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte-endothelium interactions in PCOS. Metabolism. 2017;71:153–162.
   PubMed Web of Science ®Google Scholar
• Khashchenko E, Vysokikh M, Uvarova E, et al. Activation of systemic inflammation and oxidative stress in adolescent girls with polycystic ovary syndrome in combination with metabolic disorders and excessive body weight. JCM. 2020;9;9(5):1399. pii:
   Google Scholar
• Laybutt DR, Preston AM, Akerfeldt MC, et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia. 2007;50(4):752–763.
   PubMed Web of Science ®Google Scholar
• Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014;43(1):1–23.
   PubMed Web of Science ®Google Scholar